Biosynthetic Technologies: Funding, Investors & Team (Sep 2026)
Biosynthetic Technologies manufactures bio-based synthetic molecules that are made from organic fatty acids found in plant oils. These highly-functional biosynthetic oils have numerous uses in the lubricant, chemical, and cosmetics industries, often outperforming their petroleum counterparts in similar applications. In addition to their high-performance properties, these renewable oils are biodegradable and nontoxic. Finally, BT holds a broad portfolio of issued and pending patents protecting these novel biosynthetic oils. It was founded in 2006 and headquartered in Irvine, California.
Biosynthetic Technologies has raised $7.5M across 1 funding round on record, the most recent a Series A of $7.5M announced in Feb 2022.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biosynthetic Technologies Company Profile and Key Stats
Latest funding round on record: Feb 2022.
Biosynthetic Technologies Funding Rounds
Biosynthetic Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Biosynthetic Technologies Funding Compared to Other Biotechnology Startups
Biosynthetic Technologies' latest round of $7.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biosynthetic Technologies in Biotechnology and Irvine
Companies Similar to Biosynthetic Technologies
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Biosynthetic Technologies Funding FAQs
What does Biosynthetic Technologies do?
Biosynthetic Technologies manufactures bio-based synthetic molecules that are made from organic fatty acids found in plant oils. These highly-functional biosynthetic oils have numerous uses in the lubricant, chemical, and cosmetics industries, often outperforming their petroleum counterparts in similar applications. In addition to their high-performance properties, these renewable oils are biodegradable and nontoxic. Finally, BT holds a broad portfolio of issued and pending patents protecting these novel biosynthetic oils. It was founded in 2006 and headquartered in Irvine, California.
How much funding has Biosynthetic Technologies raised?
Biosynthetic Technologies has raised $7.5M across 1 round on record. The most recent is a Series A of $7.5M announced in Feb 2022.
When did Biosynthetic Technologies last raise funding?
Biosynthetic Technologies' most recent funding round on record is a Series A of $7.5M, announced in Feb 2022.
Who is the CEO of Biosynthetic Technologies?
Mark Miller is listed as CEO at Biosynthetic Technologies.
Where is Biosynthetic Technologies headquartered?
Biosynthetic Technologies is based in Irvine, California, United States.
How many employees does Biosynthetic Technologies have?
Biosynthetic Technologies is in the 11-50 employee band.
How does Biosynthetic Technologies' funding compare to other Biotechnology startups?
Biosynthetic Technologies' latest round of $7.5M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Biosynthetic Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biosynthetic Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.